Nasdaq

Vistin Pharma ASA : Call for extraordinary general meeting

10-10-2017

Oslo, Norway, 10 October 2017

Vistin Pharma ASA (OSE: VISTIN), please find attached the call for the extraordinary general meeting in Vistin Pharma, to be held on 2 November at 10:00 CET at Østensjøveien 27, Oslo. The formal call has been sent to all shareholders registered in the Norwegian Central Security Depository (VPS).

The complete set of documents relating to the general meeting will be made available on
www.vistin.com/investors/category455.html
.

For further information, please contact:

Gunnar Manum


CFO


+47 95 17 91 90


gunnar.manum@vistin.com

 
 
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Vistin Pharma ASA via GlobeNewswire

HUG#2141019